tiprankstipranks
Advertisement
Advertisement

PLX Stock Latest News

Protalix Earnings Call: EU Win, Cash Boost, Trade-Offs
Company AnnouncementsProtalix Earnings Call: EU Win, Cash Boost, Trade-Offs
21h ago
PLX
Protalix: EU Approval and Commercial Tailwinds for Elfabrio Underscore Undervalued Upside
PremiumRatings
Protalix: EU Approval and Commercial Tailwinds for Elfabrio Underscore Undervalued Upside
14d ago
PLX
PLX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
PLX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
24d ago
PLX
Protalix Gains EU Approval for Extended Elfabrio Dosing
PremiumCompany Announcements
Protalix Gains EU Approval for Extended Elfabrio Dosing
24d ago
8K
PLX
Protalix, Chiesi Global Rare Diseases: EC approves dosing regimen for Elfabrio
PremiumThe Fly
Protalix, Chiesi Global Rare Diseases: EC approves dosing regimen for Elfabrio
24d ago
PLX
Protalix Advances RELEASE Gout Trial, Sharpening Its Long Term Biotech Upside
PremiumCompany AnnouncementsProtalix Advances RELEASE Gout Trial, Sharpening Its Long Term Biotech Upside
1M ago
PLX
Protalix Highlights Positive EMA Opinion on Elfabrio Dosing
Premium
Company Announcements
Protalix Highlights Positive EMA Opinion on Elfabrio Dosing
2M ago
8K
PLX
Protalix Wins EMA Panel Backing for New Elfabrio Dosing
Premium
Company Announcements
Protalix Wins EMA Panel Backing for New Elfabrio Dosing
2M ago
8K
PLX
Protalix, Chiesi Global: CHMP issues positive opinion for Elfabrio dosing
PremiumThe Fly
Protalix, Chiesi Global: CHMP issues positive opinion for Elfabrio dosing
2M ago
PLX
Protalix outlines 2026 rare-disease growth and pipeline strategy
PremiumCompany Announcements
Protalix outlines 2026 rare-disease growth and pipeline strategy
3M ago
8K
PLX
Protalix: Pipeline Expansion and Elfabrio Growth Drive Attractive Risk‑Reward and Undervalued Buy Rating
PremiumRatings
Protalix: Pipeline Expansion and Elfabrio Growth Drive Attractive Risk‑Reward and Undervalued Buy Rating
3M ago
PLX
Protalix, Secarna Pharmaceuticals enter collaboration and option agreement
PremiumThe Fly
Protalix, Secarna Pharmaceuticals enter collaboration and option agreement
4M ago
PLX
Protalix price target lowered to $12 from $15 at H.C. Wainwright
PremiumThe FlyProtalix price target lowered to $12 from $15 at H.C. Wainwright
4M ago
PLX
Protalix BioTherapeutics Reports Strong Revenue Growth in 2025
Premium
Company Announcements
Protalix BioTherapeutics Reports Strong Revenue Growth in 2025
5M ago
PLX
Protalix BioTherapeutics’ Earnings Call Highlights Growth and Challenges
Premium
Company Announcements
Protalix BioTherapeutics’ Earnings Call Highlights Growth and Challenges
5M ago
PLX
Protalix reports Q3 EPS 3c, consensus 5c
PremiumThe Fly
Protalix reports Q3 EPS 3c, consensus 5c
5M ago
PLX
PLX Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
PLX Upcoming Earnings Report: What to Expect?
5M ago
PLX
Protalix Seeks EMA Re-examination for Elfabrio Dosing
PremiumCompany Announcements
Protalix Seeks EMA Re-examination for Elfabrio Dosing
5M ago
8K
PLX
Protalix Faces EMA Setback on Elfabrio® Dosing
PremiumCompany Announcements
Protalix Faces EMA Setback on Elfabrio® Dosing
6M ago
8K
PLX
Protalix, Chiesi Global: CHMP issues negative opinion for Elfabrio
PremiumThe FlyProtalix, Chiesi Global: CHMP issues negative opinion for Elfabrio
6M ago
PLX
Protalix BioTherapeutics Reports Robust Growth Amid Challenges
Premium
Company Announcements
Protalix BioTherapeutics Reports Robust Growth Amid Challenges
7M ago
PLX
Protalix Amends Market Offering Agreement with H.C. Wainwright
Premium
Company Announcements
Protalix Amends Market Offering Agreement with H.C. Wainwright
7M ago
8K
PLX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >